The home medical equipment (HME) sector is confronting a major supply disruption after Medline Industries announced a voluntary product removal, discontinuation, and complete market exit for all of its branded hospital beds and related accessories. The action, triggered by potential fire hazards in electrical components, has affected more than 771,000 units and prompted an Early Alert from the U.S. Food and Drug Administration citing two deaths and 16 serious injuries linked to fire, entrapment, and asphyxiation risks.
On October 14, 2026, Medline sent customers an Urgent Medical Device Field Safety Notice covering all Medline Brand beds, including homecare, bariatric, and long-term care models, plus associated pendants, accessories, replacement parts, and any order packages containing a bed. The company identified a potential fire hazard involving the beds’ electrical systems—specifically hand-control pendants, control/motor boxes, and actuators or motors. Under certain conditions, including excessive loading, jammed components, fluid ingress into the pendant, use of extension cords, or non-Medline or unapproved accessories, the electrical parts can overheat. This may produce smoking, sparking, melting, burning, or fire.
The FDA’s Early Alert, issued later in October, confirmed that as of October 20 the company had received reports of two deaths and 16 serious injuries associated with these issues. The agency also noted risks from bed accessories and loose or unstable rails that could lead to patient entrapment or asphyxiation. Medline had earlier notified customers of the product removal and market exit; the FDA’s public alert highlighted the scale and severity of the reported events.
On October 24, Medline issued updated guidance developed in consultation with the FDA. Customers may continue using existing Medline Brand beds, rails, mattresses, and accessories in accordance with revised safety instructions until the units are repaired or replaced. Key precautions include unplugging the bed from the electrical outlet when not actively adjusting it, avoiding extension cords, and ensuring a second person is available when possible during use or movement. Medline is establishing two pathways: certain existing beds may be eligible for repair, while others will qualify for replacement or a full or partial refund of the original purchase price. The company is also providing safety-instruction labels for placement on affected beds. Customers who do not receive a label by November 30 are instructed to contact Medline Recall Customer Service.
The FDA’s listing of 771,127 affected units underscores the breadth of the action. Industry participants have described the number as massive. Peter Loope, president of Graham-Field, noted that every manufacturer will be busy for months filling the resulting void, with elevated demand expected to last at least through spring.
HME providers that previously stocked Medline beds are now facing immediate shortages and operational strain. Nikki Short, managing director of Austin Medical Supplies in Easton, Maryland, reported that backorders with Drive Medical, which had been running three to four weeks, have lengthened further, and other suppliers in the region are completely out of beds. Providers are fielding daily calls about availability. Ryan Cordeiro, COO of Louis & Clark Medical Supply in Springfield, Massachusetts, described triaging limited inventory by prioritizing hospital discharges over cash sales to keep patients safe at home and maintain referral relationships. Michael McDonald of Clinical 1 Home Medical in Weymouth, Massachusetts, said the evolving guidance created uncertainty, though the repair-or-replace options offered some relief compared with an immediate full-replacement scenario that would have been financially and operationally disastrous.
Manufacturers are moving to expand capacity. Drive Medical has accelerated production, expanded distribution, and increased inventory commitments. The company expects additional stock to become available beginning in mid-November, supported by a new distribution center in Savannah, Georgia. CEO Derek Lampert stated that delays in access to critical equipment ultimately affect patient care, which is why the firm acted immediately. Graham-Field, with four U.S. production facilities, is leveraging domestic manufacturing to respond more quickly than importers facing 10- to 12-week lead times. Loope indicated that some customers are now willing to pay more for quality products that can be delivered promptly, potentially shifting purchasing criteria away from a pure focus on the lowest price.
The recall also raises practical questions for providers and patients. Many beds were obtained through Medicare’s capped-rental program or purchased outright; the situation may intersect with Medicare’s five-year replacement rules if patients require new equipment sooner than scheduled. Providers emphasize the need to balance patient safety with operational realities while alternative products become available.
This episode illustrates the tight margins and concentrated supply base in certain segments of the durable medical equipment market. Hospital beds are essential for safe transitions from acute care to home or long-term care settings, supporting mobility, pressure-injury prevention, and caregiver management. When a major supplier exits a category, the ripple effects reach patients, families, discharge planners, and remaining manufacturers simultaneously. Ongoing coordination among Medline, the FDA, alternative suppliers, and HME providers will determine how quickly the gap is closed and whether longer-term preferences for quality and availability reshape purchasing patterns.
As of early November 2026, providers continue to manage limited inventories strategically while manufacturers work to increase output. Patients and caregivers using Medline Brand beds are advised to follow the updated safety instructions, unplug units when not adjusting them, avoid extension cords, and contact their equipment provider or Medline for information on repair, replacement, or refund options. The FDA has indicated it will update its Early Alert page as significant new information becomes available.
The Medline bed action remains one of the most consequential developments in the medical-surgical supply niche during the final week of October and the start of November, underscoring both the importance of reliable product safety systems and the industry’s capacity to adapt when a major product line is withdrawn.
